Physician profile
Jared C Dunn
NPI 1003823808
$1,877.10
in general payments reported to CMS, 2019-2025
10 companies · $30.35 in 2025
The $30.35 reported for 2025 was less than what a typical Sports Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $100).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $27.96 · 2021: $99.64 · 2022: $1,234 · 2023: $128 · 2024: $64.15 · 2025: $30.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $1,200.00 | 2022 | |
| Ferring Pharmaceuticals INC. | $184.69 | 2019 | |
| Bioventus LLC | $111.91 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Pfizer INC. | $111.47 | 2019-2025 | |
| Pacira Therapeutics, INC. | $92.79 | 2019-2021 | |
| Medtronic, INC. | $72.80 | 2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $58.67 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $18.86 | 2023 | Orthovisc, Monovisc |
| Solventum Corporation | $13.40 | 2024 | Prevena |
| Kci USA, INC. | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.